[ U.S. CDMRP Ovarian Cancer Research Program Proteogenomics Research Award | Research Funding ]
Event details
| Date | 01.04.2021 |
| Category | Call for proposal |
Aim: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the Ovarian Cancer Research Program (OCRP) Awards. The OCRP Proteogenomics Research Award supports the use of proteomics and/or genomics to explore new concepts or theories in ovarian cancer. The award is intended to support the genomic and/or transcriptomic and/or proteomic analysis of currently available clinical specimens with a focus on answering biologic and pathophysiologic questions of clinical relevance in ovarian cancer. The proposed research question should be innovative and have the potential to make an impact on ovarian cancer.
Clinical trials are not allowed under the Proteogenomics Research Award mechanism. The analysis of clinical trial-derived specimens and/or large patient specimen cohorts is encouraged. Preliminary data are not required but are allowed
Funding: max. $250’000
Duration: 2 years
Eligibility: Investigators at the level of postdoctoral fellow or clinical fellow (or equivalent) and above may be named by the organization as the Principal Investigator (PI) on the application. An eligible PI, regardless of ethnicity, nationality, or citizenship status, must be employed by, or affiliated with, an eligible organization. Foreign organizations, foreign public entities, and international organizations, are eligible to apply.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a preproposal narrative, and a list of collaborators and key personnel as suggested on the platform. Full applications (by invitation) will be made via a Grants.gov workspace. Full application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 5:00 p.m. Eastern time (ET), April 01, 2021
Full Application Deadline: 11:59 p.m. ET, July 08, 2021 (by invitation)
Grants.gov Funding Opportunity Number: W81XWH-21-OCRP-PGRA
Further information
Clinical trials are not allowed under the Proteogenomics Research Award mechanism. The analysis of clinical trial-derived specimens and/or large patient specimen cohorts is encouraged. Preliminary data are not required but are allowed
Funding: max. $250’000
Duration: 2 years
Eligibility: Investigators at the level of postdoctoral fellow or clinical fellow (or equivalent) and above may be named by the organization as the Principal Investigator (PI) on the application. An eligible PI, regardless of ethnicity, nationality, or citizenship status, must be employed by, or affiliated with, an eligible organization. Foreign organizations, foreign public entities, and international organizations, are eligible to apply.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a preproposal narrative, and a list of collaborators and key personnel as suggested on the platform. Full applications (by invitation) will be made via a Grants.gov workspace. Full application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 5:00 p.m. Eastern time (ET), April 01, 2021
Full Application Deadline: 11:59 p.m. ET, July 08, 2021 (by invitation)
Grants.gov Funding Opportunity Number: W81XWH-21-OCRP-PGRA
Further information
- To see the program announcement, navigate to the search page on Grants.gov and search for the Opportunity Number W81XWH-21-OCRP-PGRA
- For questions about the eBRAP or Grants.gov platforms, contact the Research Office.
Practical information
- General public
- Free